Isolation of Metallo Beta Lactamases from Clinical Sample (MBL)

Jashmi Chandraker *

School of Sciences, MATS University Raipur, Chhattisgarh, India.

Ashish Saraf

School of Sciences, MATS University Raipur, Chhattisgarh, India.

Sachin Chandraker

School of Sciences, MATS University Raipur, Chhattisgarh, India.

Kanupriya Dubey

School of Sciences, MATS University Raipur, Chhattisgarh, India.

*Author to whom correspondence should be addressed.


Abstract

The rapid spread of acquired metallo-beta-lactamases (MBLs) among major Gram-negative pathogens is an emerging threat and a matter of particular concern worldwide. Carbapenems are among the  few useful antibiotics against gram negative bacteria particularly those  with extended spectrum beta-lactamase. Resistant to carbapenem is mediated by loss of outer membrane proteins and production of beta lactamase that is capable of hydrolyzing carbapenems.During this study period, 80 different clinical samples were collected from various hospitals of Raipur. All clinical samples were processed according to standard microbiological methods. Isolated GNRs were subjected to susceptibility testing against antibiotics by disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.  Carbapenem-resistant isolates were subjected to the detection of MBL production by different methods.  Out of 80 samples, 28 (35%) samples showed significant growth. MBL production was observed in 20 samples.

Keywords: MBL, ESBLs, carbapenem-resistant gram-negative, CDT, DDST


How to Cite

Chandraker, Jashmi, Ashish Saraf, Sachin Chandraker, and Kanupriya Dubey. 2021. “Isolation of Metallo Beta Lactamases from Clinical Sample (MBL)”. Journal of Advances in Microbiology 21 (2):68-73. https://doi.org/10.9734/jamb/2021/v21i230329.

Downloads

Download data is not yet available.